Exact Mass: 474.2002
Exact Mass Matches: 474.2002
Found 500 metabolites which its exact mass value is equals to given mass value 474.2002
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sildenafil
Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections; Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra); Sildenafil citrate, sold under the names Viagra, Revatio and generically under various other names, is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. Viagra pills are blue and diamond-shaped with the words Pfizer on one side, and VGR xx (where xx stands for 25, 50 or 100, the dose of that pill in milligrams) on the other. Its primary competitors on the market are tadalafil (Cialis), and vardenafil (Levitra). Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Quinapril hydrochloride
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
N-[2-(Diacetylamino)-3-(4-isothiocyanatophenyl)propyl]-N-[2-(diacetylamino)propyl]acetamide
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].
Acetyl-arginyl-glycyl-aspartyl-serinamide
Ibrutinib metabolite M37
MeOSuc-AAPA-CMK
Mitopodozidum
N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester
5alpha,6beta,8alpha-Trihydroxy-28-norisotoonafolin
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (E)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane B
ligustrin-<4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate>|ligustrin-[4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate]
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane A
NSC 72274; Podophyllic acid ethylhydrazide; Podophyllinic acid 2-ethylhydrazide
8beta-5-(4,5-dihydroxytigloyl)-4-hydroxytigloyloxydesacetylzuubergenin|8beta-5-<4,5-dihydroxytigloyl>-4-hydroxytigloyloxydesacetylzuubergenin
ligustrin-4-hydroxy-5-(2-1,2-dihydroxyacryloyl)-tiglate
Carvacrol 2-O-??-glucopyranosyl-(1鈥樏傗垎2)-??-glucopyranoside|carvacrol 20O-beta-glucopyranosyl-(1-2)-beta-glycopyranoside
10-beta-D-glucopyranosyloxy-3,9-dimethoxy-7-methoxymethyl-5H-dibenzo[a,c][7]annulene|subavenoside E
lobarin
A member of the class of 2-benzofurans that is 3-butyl-3-hydroxy-2-benzofuran-1(3H)-one substituted by a 3-carboxy-4,6-dihydroxy-2-pentylphenoxy group and a methoxy group at positions 4 and 6, respectively. It is a metabolite isolated from the Sumatran lichen, Stereocaulon halei.
desacetoxyzuubergenin-8beta-4-hydroxy-5-(1,2-dihydroxyethylacryloyl)-tiglate
3alpha,4alpha-epoxyligustrin-4-hydroxy-5-(4-hydroxytigloyl)-tiglate
4-hydroxy-2-isopropyl-5-methylphenyl O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside
(aS,5S,6S,7S)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-5-[Ac]oxybenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol|schisanwilsonin F
Asn Val Gln Asp
C25H30O9_(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
sildenafil
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Asp Asn Arg
Ala Asp Arg Asn
Ala Glu Gln Gln
Ala Asn Asp Arg
Ala Asn Arg Asp
Ala Gln Glu Gln
Ala Gln Gln Glu
Ala Arg Asp Asn
Ala Arg Asn Asp
Cys Pro Gln Gln
Cys Gln Pro Gln
Cys Gln Gln Pro
Asp Ala Asn Arg
Asp Ala Arg Asn
Asp Phe Gly His
Asp Phe His Gly
Asp Phe Pro Pro
Asp Gly Phe His
Asp Gly His Phe
Asp Gly Gln Arg
Asp Gly Arg Gln
Asp His Phe Gly
Asp His Gly Phe
Asp Ile Met Pro
Asp Ile Asn Asn
Asp Ile Pro Met
Asp Leu Met Pro
Asp Leu Asn Asn
Asp Leu Pro Met
Asp Met Ile Pro
Asp Met Leu Pro
Asp Met Pro Ile
Asp Met Pro Leu
Asp Asn Ala Arg
Asp Asn Ile Asn
Asp Asn Leu Asn
Asp Asn Asn Ile
Asp Asn Asn Leu
Asp Asn Gln Val
Asp Asn Arg Ala
Asp Asn Val Gln
Asp Pro Phe Pro
Asp Pro Ile Met
Asp Pro Leu Met
Asp Pro Met Ile
Asp Pro Met Leu
Asp Pro Pro Phe
Asp Gln Gly Arg
Asp Gln Asn Val
Asp Gln Arg Gly
Asp Gln Val Asn
Asp Arg Ala Asn
Asp Arg Gly Gln
Asp Arg Asn Ala
Asp Arg Gln Gly
Asp Val Asn Gln
Asp Val Gln Asn
Glu Ala Gln Gln
Glu Glu Pro Thr
Glu Glu Thr Pro
Glu Gly Asn Arg
Glu Gly Arg Asn
Glu Met Pro Val
Glu Met Val Pro
Glu Asn Gly Arg
Glu Asn Asn Val
Glu Asn Arg Gly
Glu Asn Val Asn
Glu Pro Glu Thr
Glu Pro Met Val
Glu Pro Thr Glu
Glu Pro Val Met
Glu Gln Ala Gln
Glu Gln Gln Ala
Glu Arg Gly Asn
Glu Arg Asn Gly
Glu Thr Glu Pro
Glu Thr Pro Glu
Glu Val Met Pro
Glu Val Asn Asn
Glu Val Pro Met
Phe Asp Gly His
Phe Asp His Gly
Phe Asp Pro Pro
Phe Gly Asp His
Phe Gly His Asp
Phe His Asp Gly
Phe His Gly Asp
Phe Pro Asp Pro
Phe Pro Pro Asp
Gly Asp Phe His
Gly Asp His Phe
Gly Asp Gln Arg
Gly Asp Arg Gln
Gly Glu Asn Arg
Gly Glu Arg Asn
Gly Phe Asp His
Gly Phe His Asp
Gly His Asp Phe
Gly His Phe Asp
Gly Asn Glu Arg
Gly Asn Arg Glu
Gly Gln Asp Arg
Gly Gln Arg Asp
Gly Arg Asp Gln
Gly Arg Glu Asn
Gly Arg Asn Glu
Gly Arg Gln Asp
His Asp Phe Gly
His Asp Gly Phe
His Phe Asp Gly
His Phe Gly Asp
His Gly Asp Phe
His Gly Phe Asp
His Met Ser Thr
His Met Thr Ser
His Ser Met Thr
His Ser Thr Met
His Thr Met Ser
His Thr Ser Met
Ile Asp Met Pro
Ile Asp Asn Asn
Ile Asp Pro Met
Ile Met Asp Pro
Ile Met Pro Asp
Ile Asn Asp Asn
Ile Asn Asn Asp
Ile Pro Asp Met
Ile Pro Met Asp
Leu Asp Met Pro
Leu Asp Asn Asn
Leu Asp Pro Met
Leu Met Asp Pro
Leu Met Pro Asp
Leu Asn Asp Asn
Leu Asn Asn Asp
Leu Pro Asp Met
Leu Pro Met Asp
Met Asp Ile Pro
Met Asp Leu Pro
Met Asp Pro Ile
Met Asp Pro Leu
Met Glu Pro Val
Met Glu Val Pro
Met His Ser Thr
Met His Thr Ser
Met Ile Asp Pro
Met Ile Pro Asp
Met Leu Asp Pro
Met Leu Pro Asp
Met Met Pro Pro
Met Asn Asn Pro
Met Asn Pro Asn
Met Pro Asp Ile
Met Pro Asp Leu
Met Pro Glu Val
Met Pro Ile Asp
Met Pro Leu Asp
Met Pro Met Pro
Met Pro Asn Asn
Met Pro Pro Met
Met Pro Val Glu
Met Ser His Thr
Met Ser Thr His
Met Thr His Ser
Met Thr Ser His
Met Val Glu Pro
Met Val Pro Glu
Asn Ala Asp Arg
Asn Ala Arg Asp
Asn Asp Ala Arg
Asn Asp Ile Asn
Asn Asp Leu Asn
Asn Asp Asn Ile
Asn Asp Asn Leu
Asn Asp Gln Val
Asn Asp Arg Ala
Asn Asp Val Gln
Asn Glu Gly Arg
Asn Glu Asn Val
Asn Glu Arg Gly
Asn Glu Val Asn
Asn Gly Glu Arg
Asn Gly Arg Glu
Asn Ile Asp Asn
Asn Ile Asn Asp
Asn Leu Asp Asn
Asn Leu Asn Asp
Asn Met Asn Pro
Asn Met Pro Asn
Asn Asn Asp Ile
Asn Asn Asp Leu
Asn Asn Glu Val
Asn Asn Ile Asp
Asn Asn Leu Asp
Asn Asn Met Pro
Asn Asn Asn Asn
Asn Asn Pro Met
Asn Asn Val Glu
Asn Pro Met Asn
Asn Pro Asn Met
Asn Gln Asp Val
Asn Gln Val Asp
Asn Arg Ala Asp
Asn Arg Asp Ala
Asn Arg Glu Gly
Asn Arg Gly Glu
Asn Val Asp Gln
Asn Val Glu Asn
Asn Val Asn Glu
Pro Cys Gln Gln
Pro Asp Phe Pro
Pro Asp Ile Met
Pro Asp Leu Met
Pro Asp Met Ile
Pro Asp Met Leu
Pro Asp Pro Phe
Pro Glu Glu Thr
Pro Glu Met Val
Pro Glu Thr Glu
Pro Glu Val Met
Pro Phe Asp Pro
Pro Phe Pro Asp
Pro Ile Asp Met
Pro Ile Met Asp
Pro Leu Asp Met
Pro Leu Met Asp
Pro Met Asp Ile
Pro Met Asp Leu
Pro Met Glu Val
Pro Met Ile Asp
Pro Met Leu Asp
Pro Met Met Pro
Pro Met Asn Asn
Pro Met Pro Met
Pro Met Val Glu
Pro Asn Met Asn
Pro Asn Asn Met
Pro Pro Asp Phe
Pro Pro Phe Asp
Pro Pro Met Met
Pro Gln Cys Gln
Pro Gln Gln Cys
Pro Thr Glu Glu
Pro Val Glu Met
Pro Val Met Glu
Gln Ala Glu Gln
Gln Ala Gln Glu
Gln Cys Pro Gln
Gln Cys Gln Pro
Gln Asp Gly Arg
Gln Asp Asn Val
Gln Asp Arg Gly
Gln Asp Val Asn
Gln Glu Ala Gln
Gln Glu Gln Ala
Gln Gly Asp Arg
Gln Gly Arg Asp
Gln Asn Asp Val
Gln Asn Val Asp
Gln Pro Cys Gln
Gln Pro Gln Cys
Gln Gln Ala Glu
Gln Gln Cys Pro
Gln Gln Glu Ala
Gln Gln Pro Cys
Gln Arg Asp Gly
Gln Arg Gly Asp
Gln Val Asp Asn
Gln Val Asn Asp
Arg Ala Asp Asn
Arg Ala Asn Asp
Arg Asp Ala Asn
Arg Asp Gly Gln
Arg Asp Asn Ala
Arg Asp Gln Gly
Arg Glu Gly Asn
Arg Glu Asn Gly
Arg Gly Asp Gln
Arg Gly Glu Asn
Arg Gly Asn Glu
Arg Gly Gln Asp
Arg Asn Ala Asp
Arg Asn Asp Ala
Arg Asn Glu Gly
Arg Asn Gly Glu
Arg Gln Asp Gly
Arg Gln Gly Asp
Ser His Met Thr
Ser His Thr Met
Ser Met His Thr
Ser Met Thr His
Ser Thr His Met
Ser Thr Met His
Thr Glu Glu Pro
Thr Glu Pro Glu
Thr His Met Ser
Thr His Ser Met
Thr Met His Ser
Thr Met Ser His
Thr Pro Glu Glu
Thr Ser His Met
Thr Ser Met His
Val Asp Asn Gln
Val Asp Gln Asn
Val Glu Met Pro
Val Glu Asn Asn
Val Glu Pro Met
Val Met Glu Pro
Val Met Pro Glu
Val Asn Asp Gln
Val Asn Glu Asn
Val Asn Asn Glu
Val Asn Gln Asp
Val Pro Glu Met
Val Pro Met Glu
Val Gln Asp Asn
Val Gln Asn Asp
(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
ETHYL 4-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE
butyl prop-2-enoate,2-methylprop-2-enoic acid,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,prop-2-enenitrile
N-[2-(4-{[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino}-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-2-oxoethyl]acetamide
MITOPODOZIDE
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1331 - Epipodophyllotoxin Compound C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents C1907 - Drug, Natural Product
pf-03814735
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol,hexanedioic acid,propane-1,3-diol
ZD 7155 hydrochloride
ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.
methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazole-[3,4-c]pyridine-3-carboxylate
Acetyl-arginyl-glycyl-aspartyl-serinamide
Ananolignan D
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
Ananolignan E
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
MSACK
D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones
(1-methylsulfonylpiperidin-4-yl) N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate
6-Amino-4-(3-{[4-(4-fluorophenyl)piperazin-1-yl]methyl}-4-methoxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
(3aS,4R,9bR)-N-(2,5-difluorophenyl)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-(4-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(3-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
methyl (1R,9S,10S,11S)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(4-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(2-chlorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-(2,3-dihydro-1H-inden-2-yl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
(1R,5S)-N-(3-chlorophenyl)-7-[4-[3-[dimethylamino(oxo)methyl]phenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (Z)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] nonanoate
SB-277011 (hydrochloride)
SB-277011 hydrochloride (SB-277011A hydrochloride) is a potent, selective, orally bioavailable and brain penetrate?dopamine D3?receptor (D3R)?antagonist with Ki values of 10.7?nM and?11.2 nM?at?rodent and human?D3R, respectively. SB-277011 hydrochloride displays 80- to 100-fold selectivity over other dopamine receptors with?pKis of 8.0, 6.0, <5.2, and 5.9 for D3, D2, 5-HT1B, and 5-HT1D receptors, respectively[1][2].